Euclidean Capital as of June 30, 2023
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 12 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 28.1 | $109M | 246k | 443.28 | |
| Ishares Tr Msci India Etf (INDA) | 27.2 | $106M | 2.4M | 43.70 | |
| Spdr Gold Tr Gold Shs (GLD) | 25.4 | $99M | 555k | 178.27 | |
| 23andme Holding Class A Com (ME) | 4.6 | $18M | 10M | 1.75 | |
| Pmv Pharmaceuticals (PMVP) | 4.1 | $16M | 2.5M | 6.26 | |
| Foghorn Therapeutics (FHTX) | 2.8 | $11M | 1.6M | 7.04 | |
| Rapt Therapeutics (RAPT) | 2.7 | $11M | 571k | 18.70 | |
| Alector (ALEC) | 1.5 | $5.9M | 981k | 6.01 | |
| Oric Pharmaceuticals (ORIC) | 1.5 | $5.8M | 748k | 7.76 | |
| Tenaya Therapeutics (TNYA) | 1.4 | $5.4M | 916k | 5.87 | |
| Ngm Biopharmaceuticals | 0.5 | $1.9M | 747k | 2.59 | |
| Surrozen | 0.1 | $442k | 803k | 0.55 |
